AIMS Companies Revenue and Competitors

Phoenix, AZ USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • AIMS Companies's estimated annual revenue is currently $45M per year.(i)
  • AIMS Companies's estimated revenue per employee is $231,000

Employee Data

  • AIMS Companies has 195 Employees.(i)
  • AIMS Companies grew their employee count by 10% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$36.3M1578%N/AN/A
#2
$0.7M1588%$1.2MN/A
#3
$3.8M26-19%N/AN/A
#4
$22.3M10628%N/AN/A
#5
$1.8M140%N/AN/A
#6
$1.5M12-20%N/AN/A
#7
$5.4M3219%N/AN/A
#8
$13.4M7137%N/AN/A
#9
$11.9M6315%N/AN/A
#10
$4.3M290%N/AN/A
Add Company

AIMS Companies was established in 2005 and purchased by Maria and Chris Mihaletos in 2007. Today, we are a leading industrial and municipal services contractor in the U.S., operating throughout nine states. Headquartered in Phoenix, AZ, we employ a talented team of over 350 employees providing safe and efficient industrial, municipal and utility services as a woman-owned (certified WBENC) organization. We are proud to have partnered with some of the best customers in our industry. We strive for excellence in every encounter with our customers and work hard to build and maintain relationships based on best-in-class service. AIMS Companies: Pipeline Video Inspection, LLC (WBENC) Holding Company AIMS Coatings, LLC a division of Pipeline Video Inspection, LLC AIMS/PVIC CA, LLC (California), a division of Pipeline Video Inspection, LLC dba AIMS Companies

keywords:N/A

N/A

Total Funding

195

Number of Employees

$45M

Revenue (est)

10%

Employee Growth %

N/A

Valuation

N/A

Accelerator

AIMS Companies News

2022-04-20 - Bill aims to push companies to ask for ID before giving access to pornography

BATON ROUGE, La. (BRPROUD) — The Louisiana Legislature is trying to protect children from porn and they're asking for adults to present...

2022-04-20 - FDA to close the door on single-arm approvals to PI3K blood ...

As safety signals mount, FDA aims to crack down on PI3K blood cancer nods ... Further, the company aims to launch its RSV candidate nirsevimab in 2023,...

2022-04-19 - Gilead, after setbacks, aims to pull a third of its revenue from ...

Another big payoff, as Gilead sees it, should come from its 20 oncology drugs currently in the pipeline. The company has 30 clinical trials underway involving...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$54.5M195-18%N/A
#2
$35M198N/AN/A
#3
$48.2M1992%N/A
#4
$31.7M1998%N/A
#5
N/A2002%N/A

AIMS Companies Executives


NameTitle
Steven HudsonChief Operating Officer
Christopher BartonChief Financial Officer
Michael DudiakChief Financial Officer
Chris MihaletosCEO